CUC Inc. (9158) AI Stock Analysis

Top Page

CUC Inc.

(TSE/TYO:9158)

Select Model

Rating:54Neutral

Price Target:JPY 773.00▲(1.98% Upside)

Action:reiterated

Date:10/31/26

The score is held back primarily by financial performance risks—persistently negative free cash flow, weak cash conversion versus earnings, and rising leverage—despite improving revenue growth and ongoing profitability. Technicals are mixed with a negative MACD and the stock below longer-term moving averages. Valuation is a relative positive due to the low P/E.

Positive Factors

Revenue GrowthThe acceleration in FY2026 revenue growth indicates improving top-line momentum after a weaker prior year. If sustained, stronger sales can expand operating scale, support investment in the care-facilities platform, and provide a more durable base for future earnings generation.

Negative Factors

Persistent Negative Free Cash FlowThree consecutive years of negative free cash flow indicate that reported profitability has not translated into surplus cash generation. Continued investment or working-capital needs may require external funding, increasing dependence on financing and reducing flexibility to fund growth internally.

CUC Inc. (9158) vs. iShares MSCI Japan ETF (EWJ)

Market Cap: JPY 22.22B
Dividend Yield: ―
Average Volume (3M): 44.61K
Price to Earnings (P/E): 9.4
Beta (1Y): 0.93
Revenue Growth: 12.29%
EPS Growth: -0.34%
Country: Japan
Employees: 5,740
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Care Facilities

CUC Inc. Business Overview & Revenue Model

Company Description

CUC Inc. delivers a diverse range of healthcare provisions across Japan, throughout Asia, and globally. Their services cover critical areas like inpatient hospital care, specialized dialysis treatments, visiting nurse programs, and home hospice suppo...

CUC Inc. Financial Statement Overview

Summary

Revenue growth improved (FY2026 up ~9.9%) and profitability remains positive, but margins compressed, leverage increased (debt-to-equity ~1.58), and cash quality is weak with operating cash flow covering only ~38% of net income and negative free cash flow for three consecutive years—raising funding and balance-sheet risk.

Income Statement

67Positive

Balance Sheet

56Neutral

Cash Flow

38Negative

Financial statement breakdown
Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	55.52B	54.35B	47.04B	33.02B	35.21B	35.31B
Gross Profit	25.73B	25.41B	19.90B	14.12B	12.55B	13.18B
EBITDA	8.00B	8.51B	8.08B	5.52B	4.93B	6.53B
Net Income	2.36B	2.85B	3.13B	2.60B	2.42B	2.71B
Balance Sheet
Total Assets	101.14B	98.05B	85.17B	62.84B	39.75B	34.53B
Cash, Cash Equivalents and Short-Term Investments	18.33B	15.84B	7.53B	8.26B	4.12B	4.36B
Total Debt	56.69B	52.53B	43.54B	26.72B	21.45B	14.90B
Total Liabilities	67.32B	64.16B	54.88B	34.83B	27.83B	24.85B
Stockholders Equity	33.43B	33.25B	29.68B	27.32B	11.70B	9.46B
Cash Flow
Free Cash Flow	0	-912.00M	-3.04B	-703.00M	-3.10B	5.79B
Operating Cash Flow	0	5.71B	2.50B	4.16B	2.36B	6.62B
Investing Cash Flow	0	-3.38B	4.45B	-14.75B	-6.68B	-1.47B
Financing Cash Flow	0	5.92B	-7.60B	14.37B	3.97B	-4.43B

CUC Inc. Technical Analysis

Technical Analysis SentimentPositive

Last Price758.00

Price Trends

50DMA748.88Positive

100DMA771.52Negative

200DMA828.00Negative

Market Momentum

MACD-9.23Negative

RSI54.48Neutral

STOCH41.45Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9158, the sentiment is Positive. The current price of 758.00 is above the 20-day moving average (MA) of 734.35, above the 50-day MA of 748.88, and below the 200-day MA of 828.00, indicating a neutral trend. The MACD of -9.23 indicates Negative momentum. The RSI at 54.48 is Neutral, neither overbought nor oversold. The STOCH value of 41.45 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:9158.

CUC Inc. Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

JP:9158 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
JP:6062	70Outperform	JPY 44.61B	11.04	―	3.14%	5.16%	37.79%
JP:2435	64Neutral	JPY 2.27B	4.70	―	3.96%	2.01%	2.55%
JP:2373	57Neutral	JPY 5.26B	18.40	―	4.35%	4.76%	-52.55%
JP:7091	55Neutral	JPY 5.30B	10.97	―	0.42%	13.29%	17.57%
JP:9158	54Neutral	JPY 22.22B	9.40	―	―	12.29%	-0.34%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
JP:7061	46Neutral	JPY 3.90B	11.78	―	5.43%	14.91%	-39.00%

* Healthcare Sector Average

Performance Comparison

JP:9158 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
JP:9158	CUC Inc.	758.00	-268.00	-26.12%
JP:2373	Care Twentyone Corporation	391.00	-67.03	-14.63%
JP:2435	Cedar. Co.,Ltd	202.00	-14.17	-6.56%
JP:6062	Charm Care Corporation	1368.00	313.27	29.70%
JP:7061	Japan Hospice Holdings Inc.	460.00	-863.95	-65.26%
JP:7091	Living Platform Ltd.	1181.00	205.12	21.02%

CUC Inc. Corporate Events

CUC Inc. Posts First-Half Loss as Profits Slide Despite Rising Revenue

Oct 29, 2026

CUC Inc. reported consolidated revenue of ¥28.7 billion for the six months ended September 30, 2026, up 9.3% year-on-year, but operating profit fell 44.7% to ¥947 million and the company swung to a net loss of ¥239 million, compared wi...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 31, 2026

CUC Inc. AI Stock Analysis